Disease/Infection News

RSS

Researchers describe case report of male monkeypox patient

In a new case study, researchers described the case of a male patient with monkeypox.

10 Aug 2022

How much plastic was used during the COVID-19 pandemic?

In a new study, researchers estimated the amount of plastic required in a SARS-CoV-2 diagnostic assay.

10 Aug 2022

Review of natural products with promising anti-SARS-CoV-2 potential

In a new study, researchers reviewed existing literature on naturally active products with therapeutic efficacy against SARS-CoV-2.

10 Aug 2022

NSF-funded institute at Georgetown University aims to advance research around viral emergence

The National Science Foundation has awarded Georgetown University $12.5 million to lead a global team of scientists in establishing a collaborative institute designed to advance research and education around viral emergence -- the process of viruses jumping from animals to humans.

10 Aug 2022

Scientists conduct comparative analysis of monkeypox virus profilin-like proteins and human profilin proteins

In a new study, researchers explored monkeypox virus proteomics and structural characteristics of the A42R protein, the only MPXV protein in the RCSB PDB (protein data bank) and the only profilin-like protein of poxviruses with known structure.

10 Aug 2022

What is the risk of COVID-19 community transmission at US universities?

In a new study, researchers assessed the risk of community transmission of COVID-19 in US universities.

10 Aug 2022

What is the correlation between monkeypox viral DNA and infectivity in clinical samples?

In a new study, researchers investigated the correlation between monkeypox virus (MPXV) infectivity and viral DNA content in clinical specimens.

10 Aug 2022

How common is chronic fatigue syndrome among patients with long COVID-19?

In a new study, researchers found that myalgic encephalitis/chronic fatigue syndrome (ME/CFS) was common in long COVID-19.

10 Aug 2022

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

Researchers evaluated all the features, especially the antigenic properties and transmission potential of SARS-CoV-2 Omicron sub-variant BA.2.75.

10 Aug 2022

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

Researchers presented a novel framework for SARS-CoV-2 genomic surveillance based on case studies from New York, the United States, and the United Kingdom in a new study.

10 Aug 2022

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers monitored the remarkably rapid Omicron BA.1 to BA.2 sublineage dominance transition in the Swedish population in early 2022 on a day-to-day basis using a customized lineage-typing RT-PCR assay.

10 Aug 2022

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

In a new study, researchers assessed the impact of the SARS-CoV-2 entry route on downstream cellular and viral processes.

10 Aug 2022

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Researchers analyzed the characteristics of coronaviruses and novel CoV vaccine candidates.

10 Aug 2022

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Researchers conducted phase 3 evaluations of the immunogenicity of the two immunization timeframes of the CoronaVac COVID-19 vaccine among Chilean adults.

10 Aug 2022

Study finds climate hazards can aggravate over half of known human infectious diseases

A recent article posted to the journal Nature Climate Change demonstrated that climate change could aggravate about 50% of recognized human pathogenic illnesses.

10 Aug 2022

British Heart Foundation funded Surrey project will address cardiac safety in novel anti-malarial agents

Understanding how drugs used to treat malaria impact the human heart is essential to finally toppling one of the world's most common but serious infections, according to researchers at the University of Surrey.

10 Aug 2022

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

An increase in the number of non-COVID-19 respiratory infections should be expected this winter, say scientists. The warning comes following the results of a new study, published in The Lancet Regional Health - Europe, which found that over 55% of respiratory disease hospitalizations during the pandemic's peak were caused by non-SARS-CoV-2 infections.

10 Aug 2022

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers described the development and applications of a 3D-printed lab-on-a-chip device that quickly detected the presence of SARS-CoV-2 in patient's saliva.

10 Aug 2022

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

Recently, 'Long COVID' is becoming a significant issue worldwide. It refers to a variety of symptoms that persist over an extended period after the patient has recovered from a novel coronavirus infection (COVID-19). In many cases, it is unclear what causes Long COVID symptoms, and there is insufficient information regarding recovery time.

10 Aug 2022

A broad sarbecovirus-neutralizing antibody cocktail

Researchers present a rational approach for identifying SARS-CoV-2 receptor-binding domain-targeted broad neutralizing antibody cocktails.

9 Aug 2022

Disease/Infection News

Researchers describe case report of male monkeypox patient

How much plastic was used during the COVID-19 pandemic?

Review of natural products with promising anti-SARS-CoV-2 potential

NSF-funded institute at Georgetown University aims to advance research around viral emergence

Scientists conduct comparative analysis of monkeypox virus profilin-like proteins and human profilin proteins

What is the risk of COVID-19 community transmission at US universities?

What is the correlation between monkeypox viral DNA and infectivity in clinical samples?

How common is chronic fatigue syndrome among patients with long COVID-19?

The features of the newly emerging SARS-CoV-2 Omicron BA.2.75 subvariant

Scientists present highly accurate novel framework for SARS-CoV-2 genomic surveillance

A direct lineage-typing RT-PCR assay reveals insights into the transition from Omicron BA.1 to BA.2 dominance in Sweden

Researchers explore SARS-CoV-2 entry route and downstream cellular and viral processes

Coronavirus biology: viral RNA synthesis, origin, and vaccines

Study evaluates two immunization schedules for the inactivated SARS-CoV-2 vaccine Coronavac

Study finds climate hazards can aggravate over half of known human infectious diseases

British Heart Foundation funded Surrey project will address cardiac safety in novel anti-malarial agents

Over 55% of respiratory disease hospitalizations during the pandemic’s peak were caused by non-SARS-CoV-2 infections, study says

A novel 3D-printed lab-on-a-chip device concurrently detects SARS-CoV-2 nucleic acid and anti-SARS-CoV-2 antibodies in saliva

Researchers collaborate on a 15-month case study to analyze patient’s recovery from impaired adrenocorticotropic hormone

A broad sarbecovirus-neutralizing antibody cocktail

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News